Geneos Wealth Management’s Dynex Capital DX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.37K Hold
715
– – ﹤0.01% 2038
2026
Q1
$9.12K Hold
715
– – ﹤0.01% 2009
2025
Q4
$10K Hold
715
– – ﹤0.01% 1965
2025
Q3
$8.79K Hold
715
– – ﹤0.01% 1997
2025
Q2
$8.74K Hold
715
– – ﹤0.01% 2373
2025
Q1
$9.31K Hold
715
– – ﹤0.01% 2287
2024
Q4
$9.04K Hold
715
– – ﹤0.01% 2086
2024
Q3
$9.12K Buy
+715
New +$8.83K ﹤0.01% 1875
2022
Q3
– Sell
-440
Closed -$7K – 2168
2022
Q2
$7K Hold
440
– – ﹤0.01% 2074
2022
Q1
$7K Sell
440
-700
-61% -$11.3K ﹤0.01% 2211
2021
Q4
$19K Buy
1,140
+700
+159% +$12.1K ﹤0.01% 1905
2021
Q3
$7K Hold
440
– – ﹤0.01% 2339
2021
Q2
$8K Hold
440
– – ﹤0.01% 2275
2021
Q1
$8K Buy
+440
New +$8.1K ﹤0.01% 2465
2020
Q2
– Sell
-1,061
Closed -$12K – 2578
2020
Q1
$12K Hold
1,061
– – ﹤0.01% 1717
2019
Q4
$18K Hold
1,061
– – ﹤0.01% 1726
2019
Q3
$15K Hold
1,061
– – ﹤0.01% 1728
2019
Q2
$17K Buy
+1,061
New +$18.7K ﹤0.01% 1702

Other funds holding DX

Geneos Wealth Management's DX Position: Q2 2026 in Review

Geneos Wealth Management held its Dynex Capital (DX) position steady in Q2 2026 at 715 shares worth $9.37K. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

Geneos Wealth Management first reported a position in DX in Q2 2019 and has held it in 18 quarters since. The position peaked at $19K in Q4 2021. 288 funds tracked by Wall St. Rank hold DX as of Q2 2026.

  • Geneos Wealth Management held 715 shares of Dynex Capital worth $9.37K as of Q2 2026.
  • Geneos Wealth Management left its Dynex Capital share count unchanged in Q2 2026.
  • Dynex Capital made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2038 holding.
  • Geneos Wealth Management first reported a position in Dynex Capital in Q2 2019 and has held it in 18 quarters since.
  • Geneos Wealth Management's Dynex Capital position peaked at $19K in Q4 2021.
  • 288 funds tracked by Wall St. Rank held Dynex Capital as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.